tenosynovitis. arthritis, muscle weakness, and abnormal oesophageal motility, lacked renal involvement, and responded to corticosteroids. Follow up of the original patients found that the inflammatory features of arthritis, myositis, and fever became less frequent, although sclerodermatous manifestations persisted.2 In adult patients severe systemic features are reported, pulmonary involvement being particularly prevalent;3 the prognosis, however, is generally reported as favourable.4 In contrast with adults, a number of reports of MCTD in children have noted thrombocytopenia and significant renal involvement, suggesting a potentially poorer outlook for children.5-7
Anti-RNP antibodies have subsequently been shown to lack specificity for MCTD, even when in high titre, as they may also be found in patients with SLE.8 Ginsburg et al failed to differentiate clinical subgroups in a large series of adult patients presenting with overlap features of SLE, scleroderma. or polymyositis by either the presence or absence of anti-RNP.9 The purpose of this study, therefore, was to review a group of children who had presented with overlap features and to assess clinical patterns and prognosis in relation to anti-nuclear antibody profiles.
Patients and methods
A retrospective chart review of 26 children diagnosed as having 'overlap syndrome' was performed. All patients were referred from within the United Kingdom. All patients showed clinical features of more than one of the connective tissue diseases SLE, scleroderma, juvenile chronic arthritis, and juvenile dermatomyositis. Clinical features included arthritis, tenosynovitis, muscle weakness, Raynaud's phenomenon, skin rashes consistent with dermatomyositis, and sclerodermatous skin involvement. All patients had been followed by one of us (BMA) throughout their illness for periods up to 24 years. Five patients have been described in a previous report."I Patients' sera were stored at -70(C until tested. Anti-nuclear antibodies were detected by immunofluorescence on HEp2 cells or mouse kidney tissue substrate, or both, at a sera dilution of 1:40 and 1:160. Precipitating antibodies to extractable nuclear antigens-Sm, RNP, Scl-70, Ro/SS-A, and La/SS-B-were determined by counterimmunoelectrophoresis or Ouchterlony double diffusion, using calf thymus, rabbit thymus, and human spleen extracts as antigen source, or both. Standard reference sera were used for defining the specific antibody system present. IgM rheumatoid factor was determined by a haemagglutination assay (RAHA, Fujirebio Inc) (eight) , and localised areas of subcutaneous calcification (four).
Eight patients had proximal and truncal muscle weakness, and a further four had pronounced myalgia. Raised muscle enzymes were found in 11 patients, all of whom had symptoms related to dermatomyositis. An abnormal electromyogram or biopsy specimen, or both, was found in four of the five cases examined. Ten children had rashes suggestive of dermatomyositis involving the face, elbows, and metacarpal/interphalanigeal joints, two experienced severe vasculitic rashes, and four had non-specific erythematous rashes, particularly over the forearms.
Serious neurologic symptoms were uncommon. One child had a seizure presumed secondary to a cerebral vasculitis as she had an extensive coexistent cutaneous vasculitis. One patient died three months after onset of disease from an 'encephalitis', but the relation to the underlying overlap syndrome is unknown as no necropsy was permitted.
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Specific investigations were performed dependent on clinical features. Oesophageal reflux, without evidence of abnormal peristalsis, was noted in one of seven barium studies. No manometric studies were performed. Chest x ray films yielded normal results in all but three cases associated with pericarditis and pleural reaction. Minor restrictive pattern abnormalities on testing of respiratory function were present in nine out of 10 patients measured. No evidence of renal abnormality was detected on routine urinalysis or measurement of serum creatinine/urea concentrations or 24 hour urinary protein excretion in any patient. The rate of glomerular filtration was normal in five patients in whom it was formally measured. No renal biopsies were performed. Only one patient developed thrombocytopenia, occurring nine years after onset of disease.
Anti-nuclear antibody specificities. All except one patient were positive for anti-nuclear antibodies on immunofluorescence. Fluorescent patterns varied, the most common being diffuse speckling with nucleolar sparing consistent with anti-RNP antibodies.'2 Anti-RNP was present in 16 out of the 26 cases, and four had precipitin lines to antigens of unknown specificity. In only four cases could no antibody to extractable nuclear antigens be shown. One patient had positive anti-DNA antibodies, and two had anti-Sm antibodies, as well as anti-RNP; none of these patients, however, satisfied criteria for a diagnosis of SLE. Anti-centromere antibodies were not detected.
Of most importance, no anti-nuclear antibody pattern or specificity correlated with any particular clinical picture. Specifically, anti-RNP did not differentiate patients by mode of onset, outcome, or other laboratory variables.
Follow up state. At time of last follow up, median 7-5 years from onset, nine patients are well, experiencing intermittent arthralgia and Raynaud's phenomenon only. Minor degrees of joint restriction due to persisting sclerodermatous change or residual arthritic involvement, or both, were noted in 10 patients; these, however, did not noticeably affect the patients' functional capacity. Only three patients experience appreciable functional impairment secondary to joint restriction. One patient has relapsing myositis three years after onset, and one patient developed a severe vasculitic disease after nine years of disease. One patient died from encephalitis three months after diagnosis.
Discussion
The clinical features in our patients, both at onset of group.bmj.com on January 21, 2018 -Published by http://adc.bmj.com/ Downloaded from MCTD.19 In summary, we report 26 children with overlap features. Although most followed a clinical pattern similar to that described for MCTD. serologically less than two thirds were found to have anti-RNP antibodies; for this reason we prefer to use the term overlap syndrome. The prognosis is usually good, but some patients progress to a sclerodermatous picture. Awareness of possible involvement of internal organs requires regular review.
syndromes.
Overlap connective tissue 
